On the use of antiangiogenetic medications for retinopathy of prematurity

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

(2011) Helen A. Mintz-Hittner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491

(2010) Luca Filippi et al.   BMC Pediatrics

Propranolol for complicated infantile haemangiomas: a case series of 30 infants

(2010) F. Manunza et al.   BRITISH JOURNAL OF DERMATOLOGY

Effects of β-blockers on glucose and lipid metabolism

(2010) Vivian A. Fonseca   CURRENT MEDICAL RESEARCH AND OPINION

Noradrenaline release in the locus coeruleus modulates memory formation and consolidation; roles for α- and β-adrenergic receptors

(2010) M.E. Gibbs et al.   NEUROSCIENCE

Hypoglycemia as a Result of Propranolol During Treatment of Infantile Hemangioma: A Case Report

(2010) Johannes M.P.J. Breur et al.   PEDIATRIC DERMATOLOGY

Severe Hypoglycemia During Successful Treatment of Diffuse Hemangiomatosis with Propranolol

(2010) Ernesto Bonifazi et al.   PEDIATRIC DERMATOLOGY

Evaluation and Treatment of Hypotension in the Preterm Infant

(2009) E.M. Dempsey et al.   CLINICS IN PERINATOLOGY

Facilitation of low-frequency stimulation-induced long-term potentiation by endogenous noradrenaline and serotonin in developing rat visual cortex

(2009) Mie Inaba et al.   NEUROSCIENCE RESEARCH

Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations

(2009) Leslie P. Lawley et al.   PEDIATRIC DERMATOLOGY

Propranolol for Severe Hemangiomas of Infancy

(2008) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE